Propharmatech receives HUF 2.3 mln fine
pixabay
Hungarian healthcare product manufacturer and distributor Propharmatech has been fined HUF 2.299 million by the Hungarian Competition Authority (GVH) on charges of misleading advertising of its DIA B dietary supplement product, Hungarian news agency MTI reported.
According to the authority, the company has made misleading statements and exaggerated claims about the beneficial health effects of DIA B, when in fact it is only classified as a general foodstuff, MTI reported. The authority added that the company has violated regulations several times in the past.
ADVERTISEMENT
Loan Officers Survey Indicates Increased Caution
Gov't Guarantees on Liabilities Climb Over 9%Â of GDP in 2021
Corvex Winds up Virtual Bank Card Project
European Capital of Culture Program Set to Boost Economy - N...
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
